Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

UT MD Anderson Cancer Center

UT MD Anderson Cancer Center in Houston, Texas, United States is listed as a site for 575 registered clinical trials, 205 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 575
Ongoing 205

This page covers the site record UT MD Anderson Cancer Center in Houston, Texas, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the UT MD Anderson Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 575 trials counted.

  • Phase 1 93 trials
  • Phase 1/2 41 trials
  • Phase 2 214 trials
  • Phase 2/3 16 trials
  • Phase 3 92 trials
  • Phase 4 2 trials
  • Not applicable 43 trials
  • Observational 74 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 205 trials
  • Completed 254 trials
  • Terminated 116 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 48

1995: 1 trials (Phase 1/2 1) 1996: 1 trials (Phase 2 1) 1999: 2 trials (Phase 2 1, Phase 1 1) 2000: 3 trials (Phase 2 2, Phase 1/2 1) 2001: 16 trials (Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1 2) 2002: 14 trials (Observational 3, Phase 2 9, Phase 1/2 1, Phase 1 1) 2003: 22 trials (Observational 4, Not applicable 3, Phase 3 3, Phase 2/3 1, Phase 2 7, Phase 1/2 2, Phase 1 2) 2004: 20 trials (Observational 4, Not applicable 2, Phase 3 3, Phase 2 8, Phase 1/2 1, Phase 1 2) 2005: 38 trials (Observational 3, Not applicable 2, Phase 3 2, Phase 2 19, Phase 1/2 1, Phase 1 11) 2006: 48 trials (Observational 9, Not applicable 3, Phase 3 6, Phase 2/3 1, Phase 2 18, Phase 1/2 4, Phase 1 7) 2007: 48 trials (Observational 12, Not applicable 4, Phase 3 3, Phase 2/3 1, Phase 2 10, Phase 1/2 3, Phase 1 15) 2008: 48 trials (Observational 11, Not applicable 9, Phase 4 1, Phase 3 3, Phase 2 15, Phase 1/2 2, Phase 1 7) 2009: 43 trials (Observational 11, Not applicable 1, Phase 3 4, Phase 2 15, Phase 1/2 5, Phase 1 7) 2010: 19 trials (Observational 2, Not applicable 1, Phase 3 2, Phase 2 8, Phase 1/2 2, Phase 1 4) 2011: 16 trials (Observational 3, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 4, Phase 1/2 3, Phase 1 3) 2012: 5 trials (Not applicable 1, Phase 2 2, Phase 1/2 1, Phase 1 1) 2013: 7 trials (Phase 3 1, Phase 2/3 1, Phase 2 2, Phase 1/2 2, Phase 1 1) 2014: 12 trials (Not applicable 1, Phase 3 3, Phase 2/3 4, Phase 2 1, Phase 1/2 2, Phase 1 1) 2015: 10 trials (Observational 1, Phase 3 3, Phase 2/3 1, Phase 2 5) 2016: 12 trials (Phase 3 2, Phase 2 6, Phase 1/2 1, Phase 1 3) 2017: 16 trials (Not applicable 1, Phase 3 6, Phase 2/3 1, Phase 2 6, Phase 1 2) 2018: 17 trials (Observational 1, Not applicable 1, Phase 3 4, Phase 2 8, Phase 1 3) 2019: 21 trials (Observational 2, Phase 3 6, Phase 2 9, Phase 1 4) 2020: 20 trials (Not applicable 1, Phase 3 7, Phase 2/3 1, Phase 2 8, Phase 1/2 2, Phase 1 1) 2021: 18 trials (Not applicable 1, Phase 3 6, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 3) 2022: 20 trials (Observational 1, Phase 3 3, Phase 2/3 1, Phase 2 9, Phase 1/2 3, Phase 1 3) 2023: 23 trials (Observational 1, Phase 3 8, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 3) 2024: 19 trials (Not applicable 2, Phase 3 5, Phase 2 10, Phase 1 2) 2025: 12 trials (Not applicable 1, Phase 3 7, Phase 2 2, Phase 1/2 1, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 11
2025 12
2024 19
2023 23
2022 20
2021 18
2020 20
2019 21
2018 17
2017 16

Showing 10 of 30 years.

Start your 14-day trial Email me all 30 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 12 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 575 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 41 lead sponsors.

Start your 14-day trial Email me all 41 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 292 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF